72.11.Z - Research and experimental development on biotechnology
10.86.Z - Manufacture of homogenised food preparations and dietetic food
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
32.50.Z - Manufacture of medical and dental instruments and supplies
47.73.Z - Dispensing chemist in specialised stores
72.12.Z - Scientific research and development
74.10.Z - Specialised design activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -53,3 | -46,7 | -43,9 | 6 |
EBITDA | -9 | |||
Income tax | 0 | 0 | 0 | |
Equity capital | 388 | 341,2 | 328,3 | -3,8 |
Operating profit (EBIT) | -52,4 | |||
Assets | 406,8 | 354,3 | 776,9 | 119,3 |
Net profit (loss) | 0 | -46,7 | -43,9 | 6 |
Net income from sale | 0 | |||
Liabilities and provisions for liabilities | 18,8 | 13,1 | 448,6 | 3326,4 |
Working assets | 284,8 | 275,7 | 86 | -68,8 |
Depreciation | 43,4 | |||
Basic operational activity income | 0 | 0,8 | -∞ | |
% | % | % | p.p. | |
Profitability of capital | -13,7 | -13,4 | 0,3 | |
Equity capital to total assets | 95,4 | 96,3 | 42,3 | -54 |
Gross profit margin | -5492,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane